Puregraf Injection (Menotrophin): Fertility Hormone Injection | for Ovulation Induction, Female Infertility Management & Assisted Reproductive Treatments (IVF Support)
Puregraf Injection contains Menotrophin, a hormone-based fertility medication used to support ovulation induction and assisted reproductive treatments. It works by stimulating the ovaries to promote the development and maturation of ovarian follicles, helping improve fertility outcomes in women undergoing treatment. It is commonly prescribed under medical supervision for conditions related to infertility and hormonal imbalance.
Product Overview
Puregraf Injection contains Menotrophin (Human Menopausal Gonadotropin - hMG), a hormonal preparation that combines Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) activity. It is primarily used in fertility treatment protocols to support ovulation induction in women and stimulate sperm production in men with certain hormonal-related fertility conditions.
The formulation works by regulating reproductive hormone activity, promoting the development of ovarian follicles in females and supporting testicular function in males. Due to its gonadotropin activity, Puregraf Injection is commonly used under medical supervision as part of assisted reproductive treatment plans.
Pharmacological Profile
| Parameter | Details |
| Active Ingredient | Menotrophin (Human Menopausal Gonadotropin) |
| Drug Class | Gonadotropin Hormone Preparation |
| Dosage Form | Injectable Solution |
| Primary Action | FSH and LH hormone activity |
Mechanism Insights (How It Works)
- Follicular Stimulation
Menotrophin provides Follicle Stimulating Hormone (FSH) activity that helps stimulate the growth and maturation of ovarian follicles, supporting egg development. - Hormonal Regulation
The Luteinizing Hormone (LH) activity helps regulate reproductive hormone levels and contributes to ovulation processes in females. - Sperm Development Support
In males, Menotrophin may help stimulate testicular function by promoting sperm production when used alongside appropriate hormonal therapy.
Administration Guidelines
- Administer Puregraf Injection only under the guidance of a qualified healthcare professional.
- The dosage and treatment schedule depend on individual fertility goals and hormonal response.
- Injection should be given through the recommended route as prescribed by the doctor.
- Regular monitoring through hormone tests and ultrasound evaluations may be required during treatment.
- Follow the complete treatment plan for better therapeutic outcomes.
Clinical Considerations
- Commonly included in assisted reproductive techniques and fertility management programs.
- Requires careful dose adjustment based on patient response.
- May increase the risk of ovarian hyperstimulation syndrome (OHSS) in some women.
- Medical supervision is essential throughout treatment to ensure safe and effective use.
Precautions
Usage
Side Effects
General Safety Information
Puregraf Injection (Menotrophin) is generally well tolerated when used under the supervision of a healthcare professional. Side effects may vary depending on individual response, dosage, and treatment duration. Most reactions are mild and temporary, but proper monitoring is important during fertility treatment.
Common Side Effects
✔ Headache
✔ Nausea or vomiting
✔ Abdominal discomfort or bloating
✔ Pain, redness, or swelling at the injection site
✔ Breast tenderness
✔ Mood changes
✔ Fatigue or dizziness
These effects are usually mild and may improve as the body adjusts to the medication.
Serious Side Effects (Rare but Important)
âš Seek medical attention if you experience:
- Signs of Ovarian Hyperstimulation Syndrome (OHSS) such as severe pelvic pain, rapid weight gain, abdominal swelling, or difficulty breathing
- Severe allergic reactions (rash, itching, swelling of the face, lips, or throat)
- Severe abdominal pain or persistent nausea and vomiting
- Sudden shortness of breath or chest pain
- Unusual swelling or fluid retention
Risk Factors & Monitoring
- Higher risk of complications may occur in patients with ovarian disorders or a history of OHSS
- Regular ultrasound scans and hormone level monitoring may be required during treatment
- Dosage adjustments are based on individual response to therapy
- Patients with thyroid, adrenal, or reproductive health conditions should inform their doctor before use
FAQs
What is Puregraf Injection used for?
Puregraf Injection (Menotrophin) is used in fertility treatments to help stimulate the development of ovarian follicles in women and support ovulation. In men, it may help improve sperm production in certain cases of infertility caused by hormonal imbalance.
How does Puregraf Injection work in the body?
Puregraf Injection contains Menotrophin, a combination of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). It works by stimulating the ovaries to produce eggs and supporting hormone activity needed for reproductive functions.
Can Puregraf Injection be used during pregnancy?
Puregraf Injection is generally not used during pregnancy. It is mainly given before conception as part of fertility treatment under the supervision of a healthcare professional.
How should I take Puregraf Injection?
Puregraf Injection should be administered exactly as prescribed by your doctor. The dosage and duration depend on your fertility condition, hormone levels, and treatment response. It is usually given by injection under medical guidance.
Interactions
General Interaction Overview
Puregraf Injection (Menotrophin) may interact with certain hormonal medicines and fertility treatments that influence reproductive hormone levels or ovarian response. These interactions can affect treatment outcomes, increase the risk of side effects, or require dose adjustments. It is important to inform your healthcare provider about all medications, supplements, and fertility therapies you are currently using.
Commonly Reported Interactions
- Other fertility medicines containing gonadotropins may increase the risk of excessive ovarian stimulation.
- Hormonal medications such as estrogen or progesterone may influence treatment response and hormone balance.
- Medicines that affect pituitary or ovarian hormone activity may alter the effectiveness of Menotrophin therapy.
- Combining with fertility treatments like assisted reproductive procedures may require close monitoring of ovarian response.
- Certain medications used for hormonal disorders may interfere with the expected therapeutic effects of Puregraf Injection.
It is important to inform your doctor about all medicines and supplements you are taking before starting Puregraf Injection to reduce the risk of unwanted interactions and ensure safe and effective fertility treatment.
| Manufacturer | : | Gufic Bioscience Ltd |
| Equivalent Brand | : | Menopur |
| Generic Search | : | Menotrophin |
Latest Products
